Stemtech Corporation (OTCQB:STEK), a US-based company announced this past Tuesday its planned merger (“Merger”) with Seacret Direct, LLC (“VIÁGO”) and now announces a proposal for a Reverse Takeover (RTO) of Eevia Health Plc (“Eevia”), a Finnish producer of bioactive organic Arctic plant extracts and nutraceuticals and has its common stock listed on the Swedish Spotlight Stock Market under the symbol “EEVIA”.
This strategic RTO marks a major milestone in the evolution of the combined companies, intending to create a vertically integrated health, wellness, and lifestyle entity that manufactures its own products and is positioned for significant growth in the global marketplace.
Reverse Takeover Structure and Valuation:
Under the proposed RTO, Eevia will acquire the assets and assume the liabilities of Stemtech and, upon completion of the Merger, VIÁGO by Eevia issuing new shares, resulting in Stemtech owning approximately 85% of Eevia, with the remaining 15% of the Eevia shares owned by its existing shareholders. The final valuation, share issuance, and terms are subject to conditions, including the negotiation of the definitive agreements, a third -party valuation, and the completion of the due diligence process.
Synergies and Strategic Rationale:
Stemtech and VIÁGO have identified Eevia’s advanced production facility in Kauhajoki, Finland, as a planned significant resource
Tag Archive for Viago
Hot Business News Today
Seacret Direct (VIAGO) and Stemtech Merge
by Team Business For Home • • 0 Comments
Stemtech Corporation (OTCQB:STEK) and Seacret Direct, LLC (doing business as VIÁGO) are pleased to announce they have reached an agreement in principle to merge their businesses. This merger represents a transformative step forward for both organizations, aiming to drive significant growth and enhance shareholder value.
Charles S. Arnold, CEO and Chairman of Stemtech, stated,
“This union positions us for accelerated growth and brings substantial value to our shareholders. Together, we are building a stronger future for our combined companies and their subsidiaries.”
Upon finalization of the merger,
Charles S. Arnold will continue as Chairman of the holding company,
VIÁGO’s Izhak Ben Shabat will assume the role of Chief Executive Officer.
The executive leadership team will be further led by Eddie Head (from VIÁGO) as President and Chief Strategy Officer and
John W. Meyer (from Stemtech) as President and Chief Operating Officer.
Arnold further commented,
“The merger creates an exciting future for VIÁGO and Stemtech, uniting our strengths and offering greater opportunities for our members, customers, and affiliates. This is a partnership rooted in mutual growth and shared vision.”
VIÁGO CEO Izhak Ben Shabat added,
“This unites two well-established companies in a public forum, maximizing value for stakeholders-customers, affiliates, and shareholders alike. It also empowers the community to share in the company’s